ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

OCUP Ocuphire Pharma Inc

1,80
0,16 (9,76%)
03 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Ocuphire Pharma Inc OCUP NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,16 9,76% 1,80 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,67 1,65 1,99 1,85 1,64
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
08.3.202423:20EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08.3.202414:21EDGAR2Form 8-K - Current report
16.2.202422:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
16.2.202422:03EDGAR2Form 8-K - Current report
15.2.202400:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202400:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202400:32EDGAR2Form 3 - Initial statement of beneficial ownership of..
15.2.202400:29EDGAR2Form 3 - Initial statement of beneficial ownership of..
24.1.202406:15EDGAR2Form EFFECT - Notice of Effectiveness
23.1.202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.1.202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.1.202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.1.202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.1.202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.1.202422:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
10.1.202423:00EDGAR2Form S-3 - Registration statement under Securities Act of..
04.1.202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202400:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202400:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202423:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.12.202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.11.202314:45EDGAR2Form 8-K - Current report
13.11.202323:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202323:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202314:48EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13.11.202314:12EDGAR2Form 8-K - Current report
03.11.202314:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.11.202314:22EDGAR2Form 3 - Initial statement of beneficial ownership of..
02.11.202313:44EDGAR2Form 8-K - Current report
01.11.202321:21EDGAR2Form 8-K - Current report
27.9.202314:45EDGAR2Form 8-K - Current report
27.9.202314:00PRNUSViatris and Ocuphire Pharma Announce FDA Approval of..
14.8.202314:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11.8.202315:27EDGAR2Form 8-K - Current report
11.8.202314:51EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01.8.202317:21EDGAR2Form 8-K - Current report

Kürzlich von Ihnen besucht

Delayed Upgrade Clock